Lexicon Pharmaceuticals (LXRX) Assets Average: 2009-2012
Historic Assets Average for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $369.4 million.
- Lexicon Pharmaceuticals' Assets Average rose 21.01% to $369.4 million in Q3 2012 from the same period last year, while for Sep 2012 it was $369.4 million, marking a year-over-year increase of 21.01%. This contributed to the annual value of $398.7 million for FY2011, which is 27.66% up from last year.
- As of Q3 2012, Lexicon Pharmaceuticals' Assets Average stood at $369.4 million, which was down 5.74% from $391.9 million recorded in Q2 2012.
- Lexicon Pharmaceuticals' Assets Average's 5-year high stood at $416.7 million during Q1 2012, with a 5-year trough of $234.1 million in Q3 2009.
- Its 3-year average for Assets Average is $362.6 million, with a median of $368.0 million in 2010.
- As far as peak fluctuations go, Lexicon Pharmaceuticals' Assets Average soared by 57.23% in 2010, and later declined by 17.04% in 2011.
- Lexicon Pharmaceuticals' Assets Average (Quarterly) stood at $240.7 million in 2009, then spiked by 53.24% to $368.9 million in 2010, then fell by 1.70% to $362.6 million in 2011, then increased by 21.01% to $369.4 million in 2012.
- Its Assets Average stands at $369.4 million for Q3 2012, versus $391.9 million for Q2 2012 and $416.7 million for Q1 2012.